New balloon catheter zaps heart rhythm problem in early trial

NCT ID NCT07294742

Ongoing Disease control Sponsor: The Third People's Hospital of Chengdu Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests a new balloon-shaped catheter that uses pulsed electric fields to treat persistent atrial fibrillation, a type of irregular heartbeat. Thirty-four adults aged 18 to 75 with the condition will receive the procedure. Researchers will check safety within 7 days and see how well the catheter creates lasting scar tissue to block faulty signals.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Balloon-shaped large-focal pulsed field ablation catheter
What this could lead to: If successful, this could provide a safer and more effective way to treat persistent atrial fibrillation, potentially reducing the need for repeat procedures.
What could go wrong: This is a very early, small study with only 34 participants, so results may not apply to everyone. The procedure carries risks like heart tissue damage or nerve injury, and long-term benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation persistent atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PERSISTENT ATRIAL FIBRILLATION

Contacts and locations

Locations

The Third People's Hospital of Chengdu

Chengdu, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.